National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 14080-14081 [2024-03818]
Download as PDF
<![CDATA[
14080
Federal Register / Vol. 89, No. 38 / Monday, February 26, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission on Childhood
Vaccines Meeting; Correction
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice; correction.
AGENCY:
HRSA published a notice in
the Federal Register on February 2,
2024, concerning 2024 calendar year
meetings of the Advisory Commission
on Childhood Vaccines (ACCV). The
notice contained incorrect dates. The
notice originally stated the 2024
calendar year meetings will take place
in ‘‘2023’’ and the meeting dates are
being updated to say ‘‘2024.’’
FOR FURTHER INFORMATION CONTACT: Pita
Gomez, Principal Staff Liaison, Division
of Injury Compensation Programs,
HRSA, 5600 Fishers Lane, 8W–25A,
Rockville, Maryland, 20857; 800–338–
2382; or ACCV@hrsa.gov
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of February 2,
2024, FR Doc. 2024–02106, page 7400,
column 2, correct the DATES caption to
read: ‘‘The ACCV meetings will be held
on:
• March 7, 2024, 1 p.m. eastern time
(ET)–4 p.m. ET;
• March 8, 2024, 1 p.m. ET–4 p.m.
ET;
• September 5, 2024, 1 p.m. ET–4
p.m. ET;
• September 6, 2024, 1 p.m. ET–4
p.m. ET.’’
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–03824 Filed 2–23–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Health Resources and Services
Administration
Meeting of the National Advisory
Committee on Rural Health and Human
Services
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
SUMMARY:
VerDate Sep<11>2014
16:23 Feb 23, 2024
Jkt 262001
notice announces that the Secretary’s
National Advisory Committee on Rural
Health and Human Services
(NACRHHS) has scheduled a public
meeting. Information about NACRHHS
and the agenda for this meeting can be
found on the NACRHHS website at:
https://www.hrsa.gov/advisorycommittees/rural-health/.
DATES: Tuesday, April 9, 2024, 9 a.m.–
5 p.m. central time (CT); Wednesday,
April 10, 2024, 9 a.m.–5 p.m. CT;
Thursday, April 11, 2024, 9 a.m.–12
p.m. CT.
ADDRESSES: This meeting will be held at
the Hyatt House, 901 Neches Street,
Austin, Texas 78701. The meeting will
also be accessible to the public via
Zoom. Please use the following
information to join the meeting: https://
us02web.zoom.us/j/83119377601.
Or One tap mobile:
+13052241968,,83119377601# U.S.
+19294362866,,83119377601# U.S.
(New York)
Or Telephone:
Dial (for higher quality, dial a number
based on your current location):
+1 305 224 1968 U.S.
+1 929 436 2866 U.S. (New York)
+1 301 715 8592 U.S. (Washington, DC)
+1 312 626 6799 U.S. (Chicago)
+1 669 900 6833 U.S. (San Jose)
+1 253 215 8782 U.S. (Tacoma)
+1 346 248 7799 U.S. (Houston)
Webinar ID: 831 1937 7601
International numbers available:
https://us02web.zoom.us/u/kwqsKE6sY.
FOR FURTHER INFORMATION CONTACT:
Sahira Rafiullah, Executive Secretary of
NACRHHS, 5600 Fishers Lane,
Rockville, Maryland 20857; 240–316–
5874; or srafiullah@hrsa.gov.
SUPPLEMENTARY INFORMATION:
NACRHHS provides advice and
recommendations to the Secretary of
Health and Human Services on policy,
program development, and other
matters of significance concerning both
rural health and rural human services.
At this meeting, NACRHHS will discuss
two topics: technology and innovation
in rural health and quality reporting by
rural health clinics. Members of the
public will have the opportunity to
provide comments.
Public participants wishing to provide
oral comments must submit a written
version of their statement at least 3
business days in advance of the
scheduled meeting. Oral comments will
be honored in the order they are
requested and may be limited as time
permits. Public participants wishing to
offer a written statement should send it
to Sahira Rafiullah, using the contact
information above, at least 3 business
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
days prior to the meeting. Individuals
who plan to attend in person and need
special assistance or another reasonable
accommodation should notify Sahira
Rafiullah at the address and phone
number listed above at least 10 business
days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–03823 Filed 2–23–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; ADRD Initiative.
Date: March 19, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Mirela Milescu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/HHS, NSC, 6001 Executive
Blvd., Rockville, MD 20852, mirela.milescu@
nih.gov, 301–496–5720.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; P01 Review.
Date: March 21–22, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Li Jia, Ph.D., Scientific
Review Officer, Scientific Review Branch,
Division of Extramural Activities, NINDS/
NIH/HHS, NSC, 6001 Executive Blvd.,
Rockville, MD 20852, 301–451–2854, li.jia@
nih.gov.
E:\FR\FM\26FEN1.SGM
26FEN1
Federal Register / Vol. 89, No. 38 / Monday, February 26, 2024 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: February 20, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–03818 Filed 2–23–24; 8:45 am]
Dated: February 21, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–03840 Filed 2–23–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; AIDS and
Cancer Specimen Resource-UM1.
Date: March 20, 2024.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Mukesh Kumar, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W126,
Rockville, Maryland 20850, 240–276–6611,
mukesh.kumar3@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
VerDate Sep<11>2014
16:23 Feb 23, 2024
Jkt 262001
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism and
Reproduction.
Date: March 7–8, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Aging, Injury, Musculoskeletal, and
Rheumatologic Disorders Study Section.
Date: March 14–15, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nketi I. Forbang, MD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006K1,
Bethesda, MD 20892, (301) 594–0357,
forbangni@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Oncology.
Date: March 14–15, 2024.
Time: 10:00 a.m. to 8:00 p.m.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
14081
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Reigh-Yi Lin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 4152,
MSC 7846, Bethesda, MD 20892, (301) 827–
6009, lin.reigh-yi@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; BRAIN
Initiative: Targeted BRAIN Circuits Projects.
Date: March 14–15, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, (301) 435–
2406, ariasj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Understanding pathogenesis and
pathophysiology of neurodegenerative
diseases.
Date: March 14, 2024.
Time: 1:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181,
MSC 7846, Bethesda, MD 20892–7846, 301–
827–7238, zhaow@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Endocrine and Metabolism Study
Section.
Date: March 14, 2024.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heather Marie Brockway,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 813H,
Bethesda, MD 20892, (301) 594–5228,
brockwayhm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–RM–
23–018: Community Partnerships to Advance
Science for Society (ComPASS): Health
Equity Research Hubs.
Date: March 15, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maria De Jesus Diaz Perez,
Ph.D., Scientific Review Officer, Center for
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 89, Number 38 (Monday, February 26, 2024)]
[Notices]
[Pages 14080-14081]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03818]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; ADRD Initiative.
Date: March 19, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852.
Contact Person: Mirela Milescu, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/HHS, NSC, 6001 Executive Blvd., Rockville, MD
20852, [email protected], 301-496-5720.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; P01 Review.
Date: March 21-22, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852.
Contact Person: Li Jia, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities, NINDS/
NIH/HHS, NSC, 6001 Executive Blvd., Rockville, MD 20852, 301-451-
2854, [email protected].
[[Page 14081]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: February 20, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03818 Filed 2-23-24; 8:45 am]
BILLING CODE 4140-01-P
